C50
Conditions
Interventions
Group 1: Patients taking Tamoxifen. The following non-invasive examinations are performed: survey of questionaire, testing of the vision (Standard ETDRS) , contrast of vision (MARS-Test), and quality
Sponsors
Universitätsaugenklinik Düsseldorf
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: All patients more than 18 years old who * have not yet received a Tamoxifen treatment but are scheduled to receive a Tamoxifen treatment (control group) * have recently received a Tamoxifen treatment or * have already received and concluded a Tamoxifen treatment.
Exclusion criteria
Exclusion criteria: * A patient's missing willingness to undergo the examinations related to the study, * physical or psychological issues which render the examination impossible * a patient's missing ability to finance or organize getting to the examination
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of the retinal and vitreous interfacetomography by an optical coherence tomography | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual acuity (by a vision test), colour vision (by a colour vision test), visual field (by an automatic test of the vision field) | — |
Countries
Germany
Contacts
Public ContactKristina Spaniol
Universitätsaugenklinik Düsseldorf
Outcome results
None listed